Get the app
US › Healthcare

Pliant Therapeutics Inc (PLRX)

US · Healthcare · Biotechnology

$1.13+5.61%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-22.4M
EPS
$-0.36
EPS estimate
$-0.33

EPS came in at -0.36 against a street estimate of -0.33 — a miss of 9.1%.

Key statistics

Market cap
$72.4M
Forward P/E
0.0
P/B
0.50
Book value
$2.37
EPS (TTM)
$-1.50
52-week high
$1.95
52-week low
$1.02
50-day MA
$1.11
200-day MA
$1.22
Beta
1.28

Analyst view

Analysts rate Pliant Therapeutics Inc a hold (2 buy, 11 hold, 0 sell out of 13) with an average price target of $2.00.

Shareholding

Insiders
2.23%
Institutions
79.32%

Largest institutional holders

FundStake
TANG CAPITAL MANAGEMENT LLC9.92%
ADAR1 Capital Management LLC4.17%
Acadian Asset Management LLC3.90%
Vanguard Capital Management, LLC3.78%
Two Sigma Investments LLC3.65%
Citadel Advisors Llc3.46%
Monaco Asset Management3.13%
Renaissance Technologies Corp2.99%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Pliant Therapeutics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.